Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Yi-Ching Yuen"'
Autor:
Joanne Lee, Hossein Tabatabaeian, Michelle Limei Poon, Nagavalli Somasundaram, Liu Xin, Yi Ching Yuen, Chia Meng Teoh, Benedict Yan, Esther Hian Li Chan, Yen Lin Chee, Sanjay De Mel, Bin Zhang, Xiao Hong Chew, Tiffany Tang, Chiea Chuen Khor, Joanne Yuen Yie Ngeow, Choon Kiat Ong, Soon Thye Lim, Wee Joo Chng, E Shyong Tai, Kee Yuan Ngiam, Soo Chin Lee, Boon Cher Goh, Anand Devaprasath D. Jeyasekharan, Yvonne Tay, Folefac Aminkeng
Publikováno v:
Blood. 140:4542-4544
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1804eb2817b21d5d95c6eb7d95241693
https://doi.org/10.1182/blood-2022-169416
https://doi.org/10.1182/blood-2022-169416
Autor:
Jasmine Goh, Sanjay De Mel, Michal M. Hoppe, Masturah Bte Mohd Abdul Rashid, Xi Yun Zhang, Patrick Jaynes, Esther Ka Yan Ng, Nur’Atiqa Diana Binti Rahmat, null Jayalakshmi, Clementine Xin Liu, Limei Poon, Esther Chan, Joanne Lee, Yen Lin Chee, Liang Piu Koh, Lip Kun Tan, Teck Guan Soh, Yi Ching Yuen, Hoi-Yin Loi, Siok-Bian Ng, Xueying Goh, Donovan Eu, Stanley Loh, Sheldon Ng, Daryl Tan, Daryl Ming Zhe Cheah, Wan Lu Pang, Dachuan Huang, Shin Yeu Ong, Chandramouli Nagarajan, Jason Yongsheng Chan, Jeslin Chian Hung Ha, Lay Poh Khoo, Nagavalli Somasundaram, Tiffany Tang, Choon Kiat Ong, Wee-Joo Chng, Soon Thye Lim, Edward K. Chow, Anand D. Jeyasekharan
Publikováno v:
Science translational medicine. 14(667)
Although combination therapy is the standard of care for relapsed/refractory non-Hodgkin’s lymphoma (RR-NHL), combination treatment chosen for an individual patient is empirical, and response rates remain poor in individuals with chemotherapy-resis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46b1b7c74cd4a099b1fd98c0c3cab1c0
https://pubmed.ncbi.nlm.nih.gov/36260690
https://pubmed.ncbi.nlm.nih.gov/36260690
Autor:
Daryl Ming Zhe Cheah, Sanjay de Mel, Masturah Bte Mohd Rashid, Jing Quan Lim, Edward Kai-Hua Chow, Choon Kiat Ong, Siok Bian Ng, Soo Yong Tan, Chun Tsu Lee, Soon Thye Lim, Joanne Lee, Wee Joo Chng, Xin Liu, Hoi-Yin Loi, Yi Ching Yuen, Tiffany Tang, Xi Yun Zhang, Li Mei Poon, Yurike Laurensia, Lip Kun Tan, Dachuan Huang, Anand D. Jeyasekharan, Esther H. L. Chan, Jasmine Goh, Esther Kam Yin Wong, Wan Lu Pang, Yen Lin Chee, Burton Kuan Hui Chia
Publikováno v:
Blood Cancer Journal, Vol 10, Iss 1, Pp 1-5 (2020)
Blood Cancer Journal
Blood Cancer Journal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74131b60825389c7226e8da1c9dcbc74
http://link.springer.com/article/10.1038/s41408-020-0276-7
http://link.springer.com/article/10.1038/s41408-020-0276-7
Autor:
Yi Ching Yuen, Choon Kiat Ong, S. de Mel, L. K Tan, Masturah Bte Mohd Rashid, Nagavalli Somasundaram, Tiffany Tang, Xi Yun Zhang, Hoi‐Y Loi, Jasmine Goh, Y. L Chee, Anand D. Jeyasekharan, David S.P. Tan, Dachuan Huang, Joanne Shu Xian Lee, Xin Liu, Wee Joo Chng, Edward Kai-Hua Chow, S. T Lim, Daryl Ming Zhe Cheah, Jason Yongsheng Chan, Esther Hian Li Chan, Patrick Jaynes, S.B. Ng, Li-Mei Poon, Liang Piu Koh, Wan Lu Pang, X Goh, T. G Soh
Publikováno v:
Hematological Oncology. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1add8e46e9d1cd83eab45a637df67aac
https://doi.org/10.1002/hon.147_2880
https://doi.org/10.1002/hon.147_2880
Autor:
Esther K Y Ng, Hoi Yin Loi, Sanjay de Mel, Xin Liu, Wan Lu Pang, Tiffany Tang, Xi Yun Zhang, Joanne Lee, Edward Kh Chow, Liang Piu Koh, Siok Bian Ng, Jasmine Goh, Soon Thye Lim, Choon Kiat Ong, Hian Li Esther Chan, Daryl Tan, Masturah Bte Mohd Abdul Rashid, Yen-Lin Chee, Nur Atiqa Diana Binte Rahmat, Michelle Poon, Wee Joo Chng, Nagavalli Somasundaram, Daryl Ming Zhe Cheah, Xueying Goh, Teck Guan Soh, Lip Kun Tan, Jason Yongsheng Chan, Michal Marek Hoppe, Dachuan Huang, Patrick Jaynes, Anand D. Jeyasekharan, Yi Ching Yuen
Publikováno v:
Blood. 138:720-720
Introduction While combination therapy is the standard of care for relapsed/ refractory non-Hodgkin lymphoma (RR-NHL), the choice of combinations for an individual patient is empirical, and response rates remain poor. Here we explore the use of a hyb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84676d3004399121037a2105bbfa72a2
https://doi.org/10.1182/blood-2021-149331
https://doi.org/10.1182/blood-2021-149331
Autor:
Eng Soo Yap, Wee Joo Chng, Yunxin Chen, Muhammad Abbas Abid, Hung Chew Wong, Liang Piu Koh, Sanjay de Mel, Yi Ching Yuen, Muhammad Bilal Abid, Adeline Lin, Li Mei Poon, Lip Kun Tan, Sathish Kumar Gopalakrishnan
Publikováno v:
Clinical lymphoma, myelomaleukemia. 18(3)
Background The current standard of care for transplant-eligible myeloma patients is novel agent-based induction, followed by high-dose chemotherapy and autologous stem cell rescue. Chemo-mobilization of peripheral blood CD34+ stem cells (PBSCs) with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a9eb8b1398af00ae3c35b9c8e7a2158
https://pubmed.ncbi.nlm.nih.gov/29398647
https://pubmed.ncbi.nlm.nih.gov/29398647
Publikováno v:
European journal of hospital pharmacy : science and practice. 24(4)
This is a case of argatroban use in a critically ill patient with heparin-induced thrombocytopaenia (HIT), presenting with unexpectedly prolonged drug clearance possibly secondary to hepatic congestion due to reduced cardiac contractility. A 63-year-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78dad2d1b7773304b6d895e4ce2c740a
https://pubmed.ncbi.nlm.nih.gov/31156946
https://pubmed.ncbi.nlm.nih.gov/31156946
Objectives The primary objective of the study was to assess the rationale of fentanyl patch initiation and continuation for pain. The secondary objectives were to analyse prescribing pattern between disciplines, monitoring criteria and adverse events
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e9f95046b2e92416aca4b443b22b627
https://europepmc.org/articles/PMC6451492/
https://europepmc.org/articles/PMC6451492/
Publikováno v:
Journal of Palliative Medicine. 15:991-997
We describe the use of systemic therapy in advanced cancer patients admitted to an acute care hospital, with a focus on targeted therapy. We aim to spotlight the utilization of targeted agents in the last months of life.Adult patients (N=252) with ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::340c497e54b33a4691b36023ccb11520
https://doi.org/10.1089/jpm.2012.0050
https://doi.org/10.1089/jpm.2012.0050
Autor:
Suk Teng Chin, Sanjay de Mel, Eng Soo Yap, Anand D. Jeyasekharan, Joanne Shu Xian Lee, Yee Mei Lee, Hian Li Esther Chan, Vanessa Cl Chong, Liu Xin, Liang Piu Koh, Yen-Lin Chee, Michelle Poon, Yi Ching Yuen
Publikováno v:
Blood. 132:4222-4222
BACKGROUND/OBJECTIVE: DLBCL is a heterogeneous disease which on gene expression profiling studies (GEP) can be divided into 2 distinct subtypes, germinal center (GCB) as well as activated B cell subtype (non GCB) based on the cell-of-origin. Immunoch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02427407c332e80b9b9b3cfc97b20e4a
https://doi.org/10.1182/blood-2018-99-119672
https://doi.org/10.1182/blood-2018-99-119672